First-line FDA-approved treatment relies on a multimodal approach of surgery, radiation, temozolomide (TMZ) chemotherapy, and tumor-treating fields. Unfortunately, the prognosis remains poor, with a ...

aKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Early Drug Development Centre, Peking University Cancer Hospital & Institute, Beijing 100142 ...

Trastuzumab deruxtecan treats metastatic HER2-positive BC and HER2-low BC. Tyrosine kinase inhibitors: Lapatinib treats metastatic HER2-positive BC. Neratinib treats early-stage HER2-positive BC.

You might have two different strengths of tablets to make up the correct dose. You take temozolomide as a capsule. You swallow it whole with a glass of water. You can take the capsules twice a day, ...

ABSTRACT: Glioblastoma (GBM) is known for its poor prognosis and aggressive nature, driving the need for advanced models that provide survival prediction to improve patient prognosis. This literature ...

Key Laboratory for Developmental Genes and Human Disease, Ministry of Education, School of Medicine, Southeast University, Nanjing 210009, China ...

Results: In the context of glioblastoma treatment, 3,323 adverse reports were associated with bevacizumab, 5,283 with temozolomide, and 427 with lomustine. The most frequently reported AEs for ...